These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Severe Venlafaxine Withdrawal Successfully Treated With a Short Course of Duloxetine. Cutler N. Prim Care Companion CNS Disord; 2017 Feb 09; 19(1):. PubMed ID: 28196312 [No Abstract] [Full Text] [Related]
7. Influence of ABCB1 polymorphisms and serum concentrations on venlafaxine response in patients with major depressive disorder. Ozbey G, Celikel FC, Cumurcu BE, Kan D, Yucel B, Hasbek E, Percin F, Guzey IC, Uluoglu C. Nord J Psychiatry; 2017 Apr 09; 71(3):230-237. PubMed ID: 28079463 [Abstract] [Full Text] [Related]
8. Venlafaxine induced QTc interval prolongation in a therapeutic dose. Bavle A. Asian J Psychiatr; 2015 Aug 09; 16():63-4. PubMed ID: 26187237 [Abstract] [Full Text] [Related]
10. Serotonin syndrome, rhabdomyolysis and convulsion associated with drug interaction between venlafaxine and amoxicillin/clavulanic acid. Fernández-Ferreiro A, Pose-Reino A, Martinez-Bahamonde F, Paris M, Guemas E, González-Barcia M, Lamas MJ. Actas Esp Psiquiatr; 2016 Sep 09; 44(5):193-202. PubMed ID: 27644102 [No Abstract] [Full Text] [Related]
11. Fourteen-Pound Fluvoxamine-Associated Weight Gain in a Young Woman with Depression and Multiple Anxiety Symptoms. Jaffe RJ, Juneja NS, Juneja NS, Jaffe RJ, Coffey BJ. J Child Adolesc Psychopharmacol; 2018 Sep 09; 28(7):488-490. PubMed ID: 30226805 [No Abstract] [Full Text] [Related]
12. Rhabdomyolysis With Acute Renal Failure Requiring Dialysis in McArdle Disease: A Role for the Antidepressant Venlafaxine? Torner S, Tinel C, Soltani Z, Rifle G, Mousson C. J Clin Psychopharmacol; 2016 Aug 09; 36(4):406-8. PubMed ID: 27300253 [No Abstract] [Full Text] [Related]
13. Apathy symptoms induced by low-dose venlafaxine: Two cases. Sato S, Sodeyama N, Matsuzaki A, Shiratori Y. Neuropsychopharmacol Rep; 2020 Jun 09; 40(2):196-197. PubMed ID: 32267090 [Abstract] [Full Text] [Related]
14. Venlafaxine and takotsubo syndrome: Can we learn more from published patient cases? Madias JE. Int J Cardiol; 2016 Dec 15; 225():73-74. PubMed ID: 27716552 [No Abstract] [Full Text] [Related]
17. Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay. Islin J, Munkboel CH, Styrishave B. Toxicol In Vitro; 2018 Mar 15; 47():63-71. PubMed ID: 29100959 [Abstract] [Full Text] [Related]
18. Differential inhibition of cardiac and neuronal Na(+) channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine. Stoetzer C, Papenberg B, Doll T, Völker M, Heineke J, Stoetzer M, Wegner F, Leffler A. Eur J Pharmacol; 2016 Jul 15; 783():1-10. PubMed ID: 27130441 [Abstract] [Full Text] [Related]
19. Venlafaxine: more dangerous than most "selective" serotonergic antidepressants. Prescrire Int; 2016 Apr 15; 25(170):96-9. PubMed ID: 27186622 [Abstract] [Full Text] [Related]
20. The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review. Bellantuono C, Vargas M, Mandarelli G, Nardi B, Martini MG. Hum Psychopharmacol; 2015 May 15; 30(3):143-51. PubMed ID: 25784291 [Abstract] [Full Text] [Related] Page: [Next] [New Search]